Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Taysha Gene Therapies, Inc. TSHA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
59/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.17
+137.2%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Taysha Gene Therapies, Inc. (TSHA), dont 28 achats et 20 ventes. Le total des achats d'initiés s'élève à $34.8M et le total des ventes d'initiés à $3.01M.

Les initiés notables ayant une activité récente comprennent Alam Kamran, Nolan Sean P., Nagendran Sukumar. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — TSHA

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-02-04 Alam Kamran Chief Financial Officer Vente Informative 1,655 $4.52 $7.48K 1,442,131
2026-01-26 Nolan Sean P. Chief Executive Officer Vente Informative 41,312 $4.61 $190.45K 2,908,257
2026-01-26 Nagendran Sukumar President and Head of R&d Vente Informative 26,918 $4.61 $124.09K 1,317,389
2026-01-26 Alam Kamran Chief Financial Officer Vente Informative 23,849 $4.61 $109.94K 1,443,786
2026-01-23 Nolan Sean P. Chief Executive Officer Vente Informative 136,789 $4.75 $649.75K 2,949,569
2026-01-23 Nagendran Sukumar President and Head of R&d Vente Informative 89,132 $4.75 $423.38K 1,344,307
2026-01-23 Alam Kamran Chief Financial Officer Vente Informative 78,968 $4.75 $375.1K 1,467,635
2026-01-12 Nolan Sean P. Chief Executive Officer Attribution de RSU 648,000 $4.86 $3.15M 648,000
2026-01-12 Nagendran Sukumar President and Head of R&d Exercice d'Options (Vente) 111,324 $0.70 $77.8K 111,359
2026-01-12 Alam Kamran Chief Financial Officer Attribution de RSU 231,000 $4.86 $1.12M 231,000
2025-12-01 Nagendran Sukumar President and Head of R&d Exercice d'Options (Vente) 260,047 $1.71 $444.68K 563,617
2025-11-28 Nagendran Sukumar President and Head of R&d Exercice d'Options (Vente) 70,172 $0.70 $49.04K 222,683
2025-09-10 Nagendran Sukumar President and Head of R&d Exercice d'Options (Vente) 41,150 $0.70 $28.76K 292,855
2025-08-21 Nagendran Sukumar President and Head of R&d Vente Informative 57,054 $2.85 $162.6K 1,165,289
2025-08-21 Alam Kamran Chief Financial Officer Vente Informative 54,491 $2.85 $155.3K 1,187,603
2025-06-02 Donenberg Phillip B. Director Attribution de RSU 113,246 $2.79 $315.39K 113,246
2025-06-02 Stalfort John A Iii Director Attribution de RSU 113,246 $2.79 $315.39K 113,246
2025-06-02 Sepp-lorenzino Laura Director Attribution de RSU 56,623 - - 105,843
2025-06-02 Long Alison S Director Attribution de RSU 56,623 - - 105,843
2025-05-30 Manning Paul B 10 Percent Owner Achat Informatif 750,000 $2.75 $2.06M 2,841,704
2025-03-11 Alam Kamran Chief Financial Officer Retenue Fiscale RSU 29,843 $1.69 $50.43K 1,242,094
2025-01-02 Nolan Sean P. Chief Executive Officer Attribution de RSU 892,500 $1.85 $1.65M 892,500
2025-01-02 Nagendran Sukumar President and Head of R&d Attribution de RSU 324,500 $1.85 $600.33K 324,500
2025-01-02 Alam Kamran Chief Financial Officer Attribution de RSU 431,000 $1.85 $797.35K 431,000
2024-06-27 Manning Paul B 10 Percent Owner Achat Informatif 1,333,333 $2.25 $3M 1,333,333
2024-05-29 Donenberg Phillip B. Director Attribution de RSU 98,440 $3.17 $312.05K 98,440
2024-05-29 Stalfort John A Iii Director Attribution de RSU 98,440 $3.17 $312.05K 98,440
2024-05-29 Sepp-lorenzino Laura Director Attribution de RSU 49,220 - - 49,220
2024-05-29 Long Alison S Director Attribution de RSU 49,220 - - 49,220
2024-02-02 Alam Kamran Chief Financial Officer Retenue Fiscale RSU 1,288 $1.51 $1.94K 840,937
2024-01-02 Nolan Sean P. Chief Executive Officer Attribution de RSU 1,184,688 $1.71 $2.03M 1,184,688
2024-01-02 Nagendran Sukumar President and Head of R&d Attribution de RSU 863,617 $1.71 $1.48M 863,617
2024-01-02 Alam Kamran Chief Financial Officer Attribution de RSU 590,413 $1.71 $1.01M 590,413
2023-12-14 Nolan Sean P. Chief Executive Officer Attribution de RSU 466,550 $0.70 $326.07K 466,550
2023-12-14 Nagendran Sukumar President and Head of R&d Attribution de RSU 334,005 $0.70 $233.44K 334,005
2023-12-14 Alam Kamran Chief Financial Officer Attribution de RSU 187,582 $0.70 $131.1K 187,582
2023-11-17 Manning Paul B 10 Percent Owner Achat Informatif 100,000 $1.63 $163K 16,566,667
2023-11-01 Long Alison S Director Inconnu - - - -
2023-11-01 Long Alison S Director Attribution de RSU 43,800 $2.39 $104.46K 43,800
2023-08-24 Alam Kamran Chief Financial Officer Vente Informative 33,000 $2.33 $76.89K 258,042
2023-08-16 Donenberg Phillip B. Director Achat Informatif 111,111 $0.90 $100K 114,111
2023-08-16 Manning Paul B 10 Percent Owner Achat Informatif 16,466,667 $0.90 $14.82M 16,466,667
2023-08-16 Nolan Sean P. Chief Executive Officer Achat Informatif 444,444 $0.90 $400K 1,535,545
2023-08-16 Stalfort John A Iii Director Achat Informatif 388,889 $0.90 $350K 884,290
2023-07-13 Session R.a. Ii 10 Percent Owner Vente Informative 5,344 $0.70 $3.74K 8,871,747
2023-07-12 Session R.a. Ii 10 Percent Owner Vente Informative 80,528 $0.71 $57.03K 8,877,091
2023-06-23 Session R.a. Ii 10 Percent Owner Vente Informative 18,100 $0.70 $12.74K 8,957,619
2023-06-22 Donenberg Phillip B. Director Attribution de RSU 36,200 $0.72 $26.06K 36,200
2023-06-22 Session R.a. Ii 10 Percent Owner Vente Informative 10,508 $0.70 $7.38K 8,975,719
2023-06-22 Stalfort John A Iii Director Inconnu - - - 495,401
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message